New Psychoactive Substances

Jul 15, 2024

Péter Sárosi

The Challenge of the Emerging Semi-Synthetic Cannabinoid Market in Europe

The lucrative and unregulated market of semi-synthetic cannabinoids is rapidly expanding across Europe, raising public health concerns and posing a legislative challenge to policymakers. The solution lies not in prohibition but in regulation.

May 16, 2024

Péter Sárosi

What Are Nitazines? Interview with Shayla Schlossenberg at the UN

You have likely heard of a new group of synthetic substances, Nitazines, increasingly sold on illicit drug markets in North America and in Europe. We interviewed Shayla Schlossenberg, Drug Service Coordinator at Release, a UK-based drug policy and human rights NGO.

Apr 29, 2024

Péter Sárosi

The New EU Drug Agency Seeks Stronger Partnership with Civil Society

The EU’s drug monitoring agency organised a meeting with civil society in Lisbon to discuss future cooperation outlined in its new mandate. Read this short report about the meeting by Marie Nougier (IDPC) and Peter Sarosi!

Apr 25, 2024

István Gábor Takács

Abandonded – Designer Drugs on the Margins of Hungarian Society

How does the use of new psychoactive substances, such as “herbal” or “crystal”, affect the Hungarian countryside and cities in 2024? How does Hungarian society treat the users of these drugs? Drug users, ex-dealers, the mayor, helpers and experts answer these questions in a new documentary by Drugreporter.

Nov 12, 2021

Péter Sárosi

Harm Reduction Unmuted

More than 400 professionals and community activists gathered in Prague to attend the 5th European Harm Reduction Conference. Watch and share Drugreporter’s video report!

May 5, 2020

Péter Sárosi

Boosters – (Not so) New Drugs in Poland

The members of Drugreporter’s video advocacy network produced a movie about the new generation of synthetic drugs that conquered Poland in 2008 – and are still popular.

Mar 24, 2020

Sam Iravani

The problem of alpha-PVP in Russia and other post-Soviet states

On Russian YouTube, there are videos of alpha-PVP users, acting in bizarre and uncontrollable ways. It’s just one small sign of a vast, hidden epidemic. Read this report from Sam Iravani!

Feb 10, 2020

Péter Sárosi

A Reality Check of the Official Data on Harm Reduction – Interview with Eberhard Schatz

The Correlation European Harm Reduction Network published its first monitoring report (download here!) of harm reduction in Europe. On this occasion, we interviewed Eberhard Schatz, one of the two coordinators of the network about new trends and challenges.

Dec 17, 2019

Péter Sárosi

The Unchallenged Rule of the Designer Drugs in Hungary

Although the drug strategy adopted by the Hungarian government in 2013 aimed to make the country drug-free by 2020, the (not so) new synthetic drugs still rule the country. After the municipal elections, there is some hope that harm reduction can return to Budapest.

Oct 17, 2019

Péter Sárosi

What Works on the Ground in Europe? – 4 Case Studies

In this report we present four best practices in the field of drug demand and harm reduction from three countries. With this report, we would like to promote the culture of evaluation both among civil society organisations and decision makers.

MENU

TOPICS

SERIES

MENU

TOPICS

SERIES

New Psychoactive Substances

The Challenge of the Emerging Semi-Synthetic Cannabinoid Market in Europe

What Are Nitazines? Interview with Shayla Schlossenberg at the UN

The New EU Drug Agency Seeks Stronger Partnership with Civil Society

Abandonded – Designer Drugs on the Margins of Hungarian Society

Harm Reduction Unmuted

Boosters – (Not so) New Drugs in Poland

The problem of alpha-PVP in Russia and other post-Soviet states

A Reality Check of the Official Data on Harm Reduction – Interview with Eberhard Schatz

The Unchallenged Rule of the Designer Drugs in Hungary

What Works on the Ground in Europe? – 4 Case Studies

MENU

ADDRESS

OUR WEBSITES

TOPICS

SERIES